<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35463535</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0377-1237</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>78</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Medical journal, Armed Forces India</Title>
          <ISOAbbreviation>Med J Armed Forces India</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rescue therapy with intravenous immunoglobulin in severe refractory dengue: A pilot study.</ArticleTitle>
        <Pagination>
          <StartPage>204</StartPage>
          <EndPage>212</EndPage>
          <MedlinePgn>204-212</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mjafi.2020.12.036</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Severe dengue causes more than 22,000 deaths annually worldwide. Complicated dengue has high mortality of 44-72%. Disordered immune system with capillary leak and thrombocytopenia are hallmark of complicated dengue. Intravenous immunoglobulin (IV Ig) therapy has shown to be effective in complicated dengue in pediatric age group with refractory shock, but studies in adults are lacking. Its immunoresuscitative role is not yet fully explored in critically ill patients with severe dengue.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is retrospective observational study of patients with complicated dengue fever who were administered IV Ig therapy in a tertiary care hospital of southern India from 01 Jan 2018 to 31 Dec 2019.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 999 patients with dengue were admitted; 754 (75.47%) were males, and 245 (24.53%) were females. A total of 402 (40.24%) patients presented with warning signs. Bleeding was seen in 121 patients (12.11%); 102 (10.21%) had shock; 29 (2.90%) had acute kidney injury and 24 (2.40%) had adult respiratory distress syndrome. Overall, four people died (mortality rate: 0.40%). IV Ig in the dose of 0.4 g/kg for 5 days was used in 13 critically ill patients where standard therapy failed, 9 patients with refractory shock (which included three with myocarditis with refractory shock), 2 with encephalitis, 2 in hemophagocytic lymphohistiocytosis. Two patients died, one with myocarditis with refractory shock and another with refractory shock.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">IV Ig therapy in critically ill patients with complicated dengue can be used as a rescue therapy.</AbstractText>
          <CopyrightInformation>© 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Padmaprakash</LastName>
            <ForeName>K V</ForeName>
            <Initials>KV</Initials>
            <AffiliationInfo>
              <Affiliation>Senior Advisor &amp; Head (Medicine &amp; Gastroenterology), INHS Kalyani, Visakhapatnam, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jha</LastName>
            <ForeName>V K</ForeName>
            <Initials>VK</Initials>
            <AffiliationInfo>
              <Affiliation>Classified Specialist (Medicine &amp; Nephrologist), Command Hospital (Air Force), Bengaluru, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sowmya Karantha</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Officer, ECHS Polyclinic, Visakhapatnam, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anurag Singh</LastName>
            <ForeName>Chauhan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Senior Advisor (Medicine), INHS Kalyani, Visakhapatnam, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamal</LastName>
            <ForeName>Deep</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Classified Specialist (Medicine), INHS Kalyani, Visakhapatnam, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jambunathan</LastName>
            <ForeName>Prashant</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Graded Specialist (Medicine), INHS Kalyani, Visakhapatnam, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Med J Armed Forces India</MedlineTA>
        <NlmUniqueID>7602492</NlmUniqueID>
        <ISSNLinking>0377-1237</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Intravenous immunoglobulin therapy</Keyword>
        <Keyword MajorTopicYN="N">Mortality</Keyword>
        <Keyword MajorTopicYN="N">Multiorgan failure</Keyword>
        <Keyword MajorTopicYN="N">Refractory shock</Keyword>
        <Keyword MajorTopicYN="N">Severe dengue</Keyword>
      </KeywordList>
      <CoiStatement>The authors have none to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35463535</ArticleId>
        <ArticleId IdType="pmc">PMC9023533</ArticleId>
        <ArticleId IdType="doi">10.1016/j.mjafi.2020.12.036</ArticleId>
        <ArticleId IdType="pii">S0377-1237(21)00017-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bhatt S., Gething P.W., Brady O.J., et al.  The global distribution and burden of dengue. Nature. 2013;496(7446):504–507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3651993</ArticleId>
            <ArticleId IdType="pubmed">23563266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanaway J.D., Shepard D.S., Undurraga A.E., et al.  The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712–723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5012511</ArticleId>
            <ArticleId IdType="pubmed">26874619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization  . WHO; April 2017. Dengue and Severe Dengue Fact Sheet.http://www.who.int/mediacentre/factsheets/fs117/en/ Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Anders K.L., Nguyet N.M., Chau N.V., et al.  Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in ho Chi Minh city, Vietnam. Am J Trop Med Hyg. 2011;84:127–134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3005500</ArticleId>
            <ArticleId IdType="pubmed">21212214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C.C., Liu S.F., Liao S.C., et al.  Acute respiratory failure in adult patients with dengue virus infection. Am J Trop Med Hyg. 2007;77:151–158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17620647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Padyana Mahesha, Karanth S., Vaidya S., Gopaldas J.A. Clinical profile and outcome of dengue fever in multidisciplinary intensive care unit of a tertiary level hospital in India. Indian J Crit Care Med. 2019 Jun;23(6):270–273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6698353</ArticleId>
            <ArticleId IdType="pubmed">31435145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization  . Revised and Expanded Edition; 2011. Regional Office for South-East Asia. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee L.K., Gan V.C., Lee V.J., Tan A.S., Leo Y.S., Lye D.C. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Neglected Trop Dis. 2012;6</Citation>
        </Reference>
        <Reference>
          <Citation>Rockey D.C. Gastrointestinal bleeding. Gastroenterol Clin N Am. 2005;34:581–588. PMID: 16303571.</Citation>
        </Reference>
        <Reference>
          <Citation>Kidney Disease: Improving Global Outcomes (KDIGO) TransplantWork Group  KDIGO Clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(suppl 3):S1–S157.</Citation>
        </Reference>
        <Reference>
          <Citation>Fardet L., Galicier L., Lambotte O., et al.  Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheum. 2014;66:2613.</Citation>
        </Reference>
        <Reference>
          <Citation>Characterization of Myocarditis during worst outbreak of Dengue infection in China. Yingying Lia, Zhongwei Hub, Yuli Huanga, Jianping Lic et al. Medicine. 2016;95 27(e4051)</Citation>
        </Reference>
        <Reference>
          <Citation>Soares C.N., Puccioni-Sohler M. Dengue encephalitis: suggestion for case definition. J Neurol Sci. 2011;306 165–165.</Citation>
        </Reference>
        <Reference>
          <Citation>Rajapakse Senaka. Intravenous immunoglobulins in the treatment of dengue illness. Trans R Soc Trop Med Hyg. 2009;103:867–870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19203771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen H.-R., Chao C.-H., Liu C.-C., et al.  Macrophage migrationinhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLoS Pathog. 2018;14(4) R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 1997;71:4226—4232.</Citation>
        </Reference>
        <Reference>
          <Citation>King C.A., Marshall J.S., Alshurafa H., Anderson R. Release of vasoactive cytokines by antibody enhanced dengue virus infec- tion of a human mast cell/basophil line. J Virol. 2000;74:7146–7150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC112233</ArticleId>
            <ArticleId IdType="pubmed">10888655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sibéril S., Elluru S.R., Negi V.S., et al.  Intravenous immunoglobulin in autoimmune andinﬂamma- tory diseases: more than mere transfer of antibodies. Transfus Apher Sci. 2007;37:103–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17765663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson U., Bjork L., Skansen-Saphir U., Andersson J. Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev. 1994;139:21–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7927412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malasit P. Complement and dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Publ Health. 1987;18:316–320.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuelsson A. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291(5503):484–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11161202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostronoff M., ostronoff F., Florêncio R., et al.  Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin. Clin Infect Dis. 2003;36:1623–1624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12802766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimaano E.M., saito M., Honda S., et al.  Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg. 2007;77:1135–1138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18165536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alejandria M. Dengue fever. Clin Evid. 2005;13:887–895.</Citation>
        </Reference>
        <Reference>
          <Citation>Alejandria Marissa. Dengue haemorrhagic fever or dengue shock syndrome in children. Clin Evid. 2009;1:917.</Citation>
        </Reference>
        <Reference>
          <Citation>Subbiah A.K., Mahajan S., Yadav R.K., Agarwal S.K. Intravenous immunoglobulin therapy for dengue capillary leak syndrome in a renal allograft recipient. Case Reports. 2018 doi: 10.1136/bcr-2018-225225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2018-225225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finfer S., Bellomo R., Boyce N., et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care Unit. N Engl J Med. 2004;350:2247–2256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15163774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarada G., Suhasini M., Venkata Settee A., Sultana Sardar, Sudhakar G. A prospective observational study of the role of intravenous immunogloblins and managing children with severe dengue unresponsive to standard WHO protocol. Int J Bioassays. 2015;4(7):4075–4076.</Citation>
        </Reference>
        <Reference>
          <Citation>Ray Ujjwayini, Dutta Soma, Bandyopadhyay Syamasis, Mondal Susovan. Infections and HLH - experience from a tertiary care centre. JAPI. Jan 2019;67:54–57.</Citation>
        </Reference>
        <Reference>
          <Citation>Ellis E.M., Sharp T.M., Pérez-Padilla J., et al.  Incidence and risk factors for developing dengue-associated hemophagocytic lymphohistiocytosis in Puerto Rico, 2008 - 2013. PLoS Neglected Trop Dis. 2016;10</Citation>
        </Reference>
        <Reference>
          <Citation>Li G.-H., Ning Z.-J., Liu Y.-M., Li X.-H. Neurological manifestations of dengue infection. Front Cell Infect Microbiol. 2017;7:449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5660970</ArticleId>
            <ArticleId IdType="pubmed">29119088</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
